Fostering Efficiency and Sustainability in the Skin Cancer Patient Pathway
ABSTRACT
Background:
Background:
Skin cancer is the most commonly diagnosed cancer. In secondary care patients enter a complex pathway, often involving excision. This multistage process likely has a significant carbon footprint, which has not been previously evaluated.
Objective:
Objective:
The aims of this study were to quantify the carbon footprint of the skin cancer excision pathway and to identify opportunities for pathway optimisation to improve both sustainability and efficiency.
Methods:
Methods:
A retrospective process mapping and life-cycle analysis of 64 patients undergoing skin cancer excision was performed for patient-facing and organisational steps from diagnosis to follow-up. Estimates for carbon dioxide emissions and areas for pathway remodelling were generated.
Results:
Results:
The carbon footprint of a patient undergoing skin cancer excision was 118.5 kgCO2eq. The perioperative phase had the highest emissions (53.1 kgCO2eq, 44.8%), but the combined diagnostic and follow-up periods were greater (65.4 kgCO2eq, 55.2%). Imaging and nuclear medicine were responsible for over a third of emissions (42.5 kgCO2eq, 35.9%).
Conclusions:
Conclusions:
This is the first study to evaluate the carbon footprint of the secondary care skin cancer excision pathway. Multiple inefficiencies were identified, and opportunities for improvement, pathway stratification, diagnostic justification, and adoption of circular economy principles were suggested changes to increase sustainability and improve standards of care.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.